Terns Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,622	455	363	472	157	-
Market Cap Growth	853.24%	25.27%	-23.08%	200.27%	-	-
Enterprise Value	3,372	96	122	298	1	-
Last Close Price	32.60	5.45	6.09	8.75	7.35	-
PS Ratio	-	-	-	-	178.64	-
PB Ratio	14.96	1.36	1.57	1.82	1.11	-
P/TBV Ratio	14.96	1.36	1.57	1.82	1.11	-
EV/Sales Ratio	-	-	-	-	1.44	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	0.19
Net Debt / Equity Ratio	-1.04	-1.03	-1.03	-1.02	-1.03	-0.90
Net Debt / EBITDA Ratio	2.72	3.51	2.57	4.58	3.36	1.69
Net Debt / FCF Ratio	3.79	5.09	3.90	5.71	3.94	2.04
Asset Turnover	-	-	-	-	0.01	-
Quick Ratio	19.21	22.89	22.06	33.43	24.34	3.28
Current Ratio	19.52	23.14	22.39	33.68	24.48	3.98
Return on Equity (ROE)	-29.12%	-29.56%	-33.89%	-27.60%	-43.83%	-68.73%
Return on Assets (ROA)	-19.94%	-20.13%	-23.08%	-17.04%	-23.94%	-39.83%
Return on Capital Employed (ROCE)	-37.90%	-29.20%	-40.00%	-22.30%	-30.90%	-53.30%
Earnings Yield	-2.22%	-18.88%	-22.49%	-11.97%	-28.08%	-
FCF Yield	-	-14.89%	-16.82%	-9.80%	-23.61%	-
Buyback Yield / Dilution	-22.41%	-11.58%	-97.76%	-58.69%	-7862.47%	-55.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.